¹²⁹Xe(XENON) MRI Program (NCT07533981) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
¹²⁹Xe(XENON) MRI Program
Canada200 participantsStarted 2026-07-01
Plain-language summary
Healthy volunteers aged 18 to 85 will undergo hyperpolarized Xenon-129 (¹²⁹Xe) MRI and pulmonary function testing. The study aims to develop evaluation tools for ventilation defect percent (VDP), signal-to-noise and contrast-to-noise ratios (SNR/CNR) of ¹²⁹Xe dissolved-phase images, and spectroscopy-based analysis.
Who can participate
Age range18 Years – 85 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patient understands study procedures and is willing to participate in the study as indicated by the patient's signature.
* Provision of written, informed consent prior to any study specific procedures.
* Males and females aged 18 to 85 years.
* Participant must be able to perform a breath-hold for 16s.
* Participant has a BMI between 18 and 40
* Participant must be able to perform reproducible pulmonary function tests (i.e., the 3 best acceptable spirograms have forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC) values that do not vary more than 5% of the largest value or more than 100 ml, whichever is greater)
* Participants are judged to be in stable health on the basis of medical history
Exclusion Criteria:
* Patient has an MR incompatible implanted mechanically, electrically, or magnetically activated device or any metal in their body which cannot be removed, including but not limited to pacemakers, neurostimulators, biostimulators, implanted insulin pumps, aneurysm clips, bioprosthesis, artificial limb, metallic fragment or foreign body, shunt, surgical staples (including clips or metallic sutures and/or ear implants) (at the discretion of the MRI Technologist).
* In the investigator's opinion, subject suffers from any physical, psychological or other condition(s) that might prevent performance of the MRI or CT, such as severe claustrophobia.
* Participants who are pregnant, breastfeeding or have a positive pregnancy test…